Skip to main content
Clinical Trials/ACTRN12616000232437
ACTRN12616000232437
Completed
未知

Medium-term clinical and radiographic outcome of DePuy Delta Xtend reverse TSA at a minimum 5 year follow-up

DePuy International Ltd0 sites68 target enrollmentFebruary 19, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
shoulder arthritis associated with rotator cuff tear
Sponsor
DePuy International Ltd
Enrollment
68
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 19, 2016
End Date
December 22, 2017
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
DePuy International Ltd

Eligibility Criteria

Inclusion Criteria

  • Retrospective analysis of a consecutive series of prospectively enrolled patients following reverse TSA for a variety of indications using the DePuy Delta Xtend reverse RSA system.

Exclusion Criteria

  • Patients excuded if surgery not carried out by pre\-designated surgeon, if a conventional TSA or other form of arthroplasty rather than a reverse TSA was performed, or if an alternative implant was used for the procedure.

Outcomes

Primary Outcomes

Not specified

Similar Trials